Thermo Scientific Orbitrap Astral mass spectrometer

The Thermo Scientific Orbitrap Astral mass spectrometer combines fast throughput, high sensitivity and deep proteome coverage to allow researchers to uncover proteins that previously evaded detection. Researchers can use this information to identify new clinical biomarkers, reveal diseases and develop interventions for everything from cardiovascular disease to cancer.

Advances in genomics have led to valuable insights into disease. Proteomics expands on this research by adding further understanding of complex and dynamic cellular-level processes that can lead to the development of drugs and diagnostics that have a material impact on human health. The Astral analyser builds on Thermo Fisher Scientific’s Orbitrap mass spectrometry platform with novel technology designed to deliver up to 2x deeper proteome coverage and up to 4x more throughput compared to current mass spectrometers, offering precise quantitation for proteomics laboratories, the company says.